Belladonna Alkaloids, Ergotamine, and Ph... Clinical Trials

• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• Patient, Provider, and Healthcare System Factors Associated with in Suboptimal Prescribing for Older Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00144001 - Active, not recruiting
  Epilepsy
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• Study of Phenobarbital Inhibition of Catamenial Epilepsy
  ClinicalTrials.gov Identifier: NCT00530413 - Recruiting
  Epilepsy
  
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002759 - Completed
  Leukemia; Lymphoma; Eye Cancer
  
• Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage
  ClinicalTrials.gov Identifier: NCT00009620 - Completed
  Intracranial Hemorrhage; Brain Injury; Brain Hemorrhage
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
  ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
  Analgesia
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
  Parkinson Disease
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
  Analgesics, Opioid.; Pain
  
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
  Chronic Hepatitis B
  
• A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
  Schizophrenia
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• Lopinavir Capsules to Kaletra or Invirase Tablets
  ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
  HIV Infections
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
  ClinicalTrials.gov Identifier: NCT00139854 - Completed
  Anxiety
  
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
  ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
  Allergy
  
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
  Allergy
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
  ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
  Chronic Pain
  
• Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
  Malaria
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
  ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
  Menopause
  
• A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
  HIV Infection
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
  HIV Infection
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
  Menopause
  
• Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
  Pain; Cancer
  
• Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics
  ClinicalTrials.gov Identifier: NCT00032682 - Completed
  Constipation; Neoplasms
  
• Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
  Pain; Cancer
  
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
  Posthepatitic Cirrhosis
  
• Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
  ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
  Smoking Cessation
  
• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
  Crohn''s Disease
  
• Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
  ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
  Pyuria; Urinary Tract Infections
  
• Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
  Myelodysplastic Syndrome (MDS)
  
• Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
  ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
  Urinary Tract Infection
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
  ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
  Parkinson's Disease
  
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
  ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
  Tobacco Dependence
  
• Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
  Rheumatoid Arthritis
  
• A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00139867 - Completed
  Parkinson''s Disease
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
  Restless Legs Syndrome
  
• Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00000484 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
  ClinicalTrials.gov Identifier: NCT00035347 - Completed
  Pneumonia
  
• Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
  ClinicalTrials.gov Identifier: NCT00544024 - Completed
  Malaria
  
• Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
  ClinicalTrials.gov Identifier: NCT00062556 - Completed
  Intermittent Claudication; Peripheral Vascular Disease
  
• Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
  ClinicalTrials.gov Identifier: NCT00328718 - Completed
  Asthma
  
• Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00396799 - Completed
  Menopause
  
• Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
  ClinicalTrials.gov Identifier: NCT00167921 - Completed
  Atrophic Vaginitis
  
• A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
  ClinicalTrials.gov Identifier: NCT00500201 - Completed
  Schizophrenia
  
• Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
  ClinicalTrials.gov Identifier: NCT00550329 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
  
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00255528 - Completed
  Hypertension
  
• A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
  ClinicalTrials.gov Identifier: NCT00232154 - Completed
  Sinusitis
  
• An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
  ClinicalTrials.gov Identifier: NCT00344383 - Completed
  Metrorrhagia
  
• Micronutrients and Enteric Infections in African Children
  ClinicalTrials.gov Identifier: NCT00156832 - Completed
  Diarrhea
  
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
  ClinicalTrials.gov Identifier: NCT00195741 - Completed
  Migraine
  
• A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
  ClinicalTrials.gov Identifier: NCT00268827 - Completed
  HIV-1; AIDS
  
• Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00343629 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• A Study Comparing the Efficacy of Long-Acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00236457 - Completed
  Schizophrenia; Psychotic Disorders
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
  ClinicalTrials.gov Identifier: NCT00098189 - Completed
  Psoriasis
  
• Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
  ClinicalTrials.gov Identifier: NCT00387010 - Completed
  Pain
  
• A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
  ClinicalTrials.gov Identifier: NCT00225810 - Completed
  Crohn's Disease
  
• A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249223 - Completed
  Schizophrenia; Psychotic Disorders
  
• An Open-Label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-Dissolving Tablet Formulation of Risperdone
  ClinicalTrials.gov Identifier: NCT00246272 - Completed
  Schizophrenia
  
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00195767 - Completed
  Bipolar I Disorder, Manic or Mixed
  
• Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00483652 - Completed
  Multiple Sclerosis
  
• Evaluation of the Usefulness to Doctors of the Risperdal® Consta® Treatment Guidebook Over a Three-Month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-Acti
  ClinicalTrials.gov Identifier: NCT00236548 - Completed
  Psychotic Disorders; Schizophrenia
  
• Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
  ClinicalTrials.gov Identifier: NCT00259987 - Completed
  Adenocarcinoma
  
• Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141570 - Completed
  Menopause
  
• Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00494962 - Completed
  Alzheimer Disease
  
• Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00300378 - Completed
  Depressive Disorder, Major
  
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00064441 - Completed
  Ulcerative Colitis
  
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00064454 - Completed
  Ulcerative Colitis
  
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00060905 - Completed
  Bipolar Disorder
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00098150 - Completed
  Atopic Dermatitis
  
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients with Dyslipidemia: A Dose-Ranging Study - SEACOAST
  ClinicalTrials.gov Identifier: NCT00082251 - Completed
  Hypercholesterolemia
  
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00067262 - Completed
  Bipolar Disorder
  
• Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
  ClinicalTrials.gov Identifier: NCT00073164 - Completed
  Schizophrenia
  
• Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00085891 - Completed
  Schizophrenia
  
• Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients with Dyslipidemia (OCEANS)
  ClinicalTrials.gov Identifier: NCT00080275 - Completed
  Hypercholesterolemia
  
• A Safety and Effectiveness Study of Methylphenidate HCl Extended-Release Tablets in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326391 - Completed
  Attention Deficit Disorder With Hyperactivity
  
• A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis (R-R MS).
  ClinicalTrials.gov Identifier: NCT00349193 - Completed
  Relapsing Remitting Multiple Sclerosis
  
• A Study To Examine The Effect And Safety Of GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol (Also Known as "Good Cholesterol")
  ClinicalTrials.gov Identifier: NCT00158899 - Completed
  Dyslipidaemia
  
• A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects with Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00139893 - Completed
  Diabetic gastroparesis
  
• Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aerug
  ClinicalTrials.gov Identifier: NCT00481689 - Completed
  Urinary Tract Infections
  
• A Multicenter, Open-Label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects with Stable Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00139789 - Completed
  Multiple Sclerosis
  
• Pediatric Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00034736 - Completed
  Pneumonia
  
• Study of Talabostat in Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00083239 - Completed
  Melanoma; Skin Cancer
  
• Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00080080 - Completed
  Lung Cancer